Interestingly, ALKBH5−/− TBM showed prolonged survival and slower tumor growth as compared to the non-transfected (NTC) control mice, suggesting the direct involvement of ‘ALKBH5’ in interfering with the efficacy of anti-PD-1 antibody. This evidence concerns the gene PDCD1 and neoplasm.